Research

seAFOod Polyp Prevention Trial re-opens

26 Sept 2014
After a period of several months when recruitment was hampered by drug supply problems, this important chemoprevention trial set in the English Bowel Cancer Screening Programme (BCSP) will be fully open for recruitment again in BCSP sites across England. Trial investigators: please be on the look-out for 'high risk' polyp cases needing one-year surveillance colonoscopy from the first week in October onwards. The Trial now needs to recruit a minimum 20 participants per month for the next 18 months or so in order to reach target. Together, we can prove that the BSG and BCSP can host large, practice-changing drug trials such as this. A big thank-you to all contributing to the Trial.
Mark Hull (Chief Investigator)

NIHR Specialty Group Newsletters

The NIHR CCRN produces a newsletter for the Specialty Groups.

PI Recognition

Earlier this year, all NIHR CRN Local Clinical Research Networks were asked to nominate 3 investigators who had made a difference to the NIHR CRN commercial portfolio under the following categories:

  • Consistently delivered to time and target
  • Delivered first commercial study
  • Delivered first global/ European patient
  • Top recruiter globally/Europe-wide
  • Worked above and beyond their call of duty to support commercial research
  • Overcame the challenges of a particularly difficult study
  • Excellent team leader and mentor

The BSG congratulates the following investigators, all of whom received signed certificates acknowledging their achievements:

Tariq Iqbal - University Hospitals Birmingham NHS Trust - GI
Kosh Agarwal - Kings College Hospital NHS Foundation Trust - Hep
Daniel Forton - St George's Hospital - Hep
Steve Ryder - Queen's Medical Centre - Hep
Raj Srirajaskanthan - University Hospitals Lewisham – Hep

New Centres Sought for C. difficile Study

alt

The RAPID trial is looking to open more recruitment centres. We are examining the effectiveness of Rifaximin in preventing recurrence of C. difficile infection. Professor Robin Spiller is the Chief Investigator of this NIHR portfolio study (UKCRN ID: 12990), being sponsored by the University of Nottingham.

To express interest and receive more information, please contact Nafisa Boota (Trial Manager, Nottingham Clinical Trials Unit). Telephone: +44 (0)115 884 4924. Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Paediatric European Digestive Diseases Clinical Research Network – PEDDCReN

PEDDCReN is an exciting new initiative with the key aim of forming a clinical trials network to study (and ultimately provide) effective medicines for paediatric patients in the speciality of Gastroenterology, Hepatology and Nutrition. It was established with the support of LINKS funding from the UEG and is led by the BSG in collaboration with various European societies and ENPR-EMA (The European Network of Paediatric Research at the European Medicines Agency). The project will support both industry and non-industry investigators in running high quality multi-centre clinical trials and your involvement is welcome.

 

Page 1 of 6